The Cost-Effectiveness of Hyperlipidemia Medication in Low- and Middle-Income Countries: A Review.

Husain, Muhammad Jami; Spencer, Garrison; Nugent, Rachel; Kostova, Deliana; Richter, Patricia

Husain, Muhammad Jami; Spencer, Garrison; Nugent, Rachel; Kostova, Deliana; Richter, Patricia.

Afiliação

Husain MJ; Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, US.
Spencer G; Center for Global Noncommunicable Diseases, RTI International, Seattle, Washington, US.
Nugent R; Center for Global Noncommunicable Diseases, RTI International, Seattle, Washington, US.
Kostova D; Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, US.
Richter P; Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, US.

Glob Heart ; 17(1): 18, 2022.

Article em En | MEDLINE | ID: mdl-35342693

Assuntos

Doenças Cardiovasculares; Hiperlipidemias; Doenças Cardiovasculares/epidemiologia; Doenças Cardiovasculares/prevenção & controle; Análise Custo-Benefício; Países em Desenvolvimento; Humanos; Hiperlipidemias/tratamento farmacológico; Hiperlipidemias/epidemiologia; Renda

Palavras-chave

Cost-effectiveness; Hyperlipidemia; Low and Middle Income Countries

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Hiperlipidemias Tipo de estudo: Health_economic_evaluation / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Glob Heart Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google